Interpretation of Elevated D‑Dimer Levels

Thrombotic Causes

Acute venous thromboembolism (VTE) markedly raises D‑dimer because coagulation and fibrinolysis are simultaneously activated. The elevation is observed in both deep‑vein thrombosis and pulmonary embolism, providing a high negative predictive value but a low positive predictive value for these conditions. 1, 2, 3

Patients with cancer—especially those with metastatic disease or receiving chemotherapy—frequently have elevated D‑dimer levels. This reflects the pro‑coagulant state associated with malignancy. 2, 4

In hospitalized, acutely ill patients with severe infection or systemic inflammation, D‑dimer testing has limited usefulness because false‑positive results are common. 1, 5

In COVID‑19 infection, a baseline D‑dimer above the upper limit of normal predicts critical illness, thrombotic complications, acute kidney injury, and mortality; levels exceeding 5 mg/L are linked to a markedly increased risk of thrombosis. 6, 7, 8

D‑dimer concentrations rise in DIC, necessitating treatment of the underlying trigger to control the coagulopathy. 1, 9

The specificity of D‑dimer for suspected pulmonary embolism declines sharply with age, reaching roughly 10 % in individuals older than 80 years. 2, 3, 4
Applying age‑adjusted cut‑offs (age × 10 µg/L for patients > 50 years) improves diagnostic performance in elderly patients. 2, 3, 4

During pregnancy, D‑dimer levels are commonly elevated, reflecting physiologic changes in coagulation. 2, 3, 4

Surgical procedures lead to transient increases in D‑dimer, reducing the test’s efficiency; the number needed to test rises from about 3 in a general emergency department to over 10 in post‑operative patients. 1, 5, 2, 4
Physical trauma also elevates D‑dimer concentrations, consistent with tissue injury‑induced activation of the coagulation cascade. 1, 5

Atrial fibrillation is associated with modestly higher D‑dimer levels, likely due to atrial stasis and low‑grade thrombin generation. 1, 5
Ischemic stroke patients may exhibit elevated D‑dimer, reflecting concurrent vascular injury and inflammation. 1, 5

In hospitalized or acutely ill populations, the high prevalence of false‑positive D‑dimer results limits its diagnostic utility. 1, 5
The positive predictive value of an elevated D‑dimer is low, making it unsuitable for confirming pulmonary embolism or deep‑vein thrombosis without additional imaging. 2, 3, 4
Considerable analytical variability exists among D‑dimer assays; optimal cut‑off values should be calibrated to the specific methodology employed. 6, 7

D‑dimer rises in many non‑thrombotic conditions because it reflects both coagulation activation and fibrinolysis; a negative result reliably excludes venous thromboembolism (VTE), whereas a positive result must be interpreted in the clinical context. 10

In hospitalized or acutely ill patients with severe infection, D‑dimer testing has limited usefulness because false‑positive results are common, reducing its diagnostic value for VTE. 10

In patients with COVID‑19, a D‑dimer level exceeding 5 mg/L yields a positive predictive value of roughly 40–50 % for thrombotic complications. [11][12]13
Baseline D‑dimer above the upper limit of normal predicts more severe disease, including critical illness, thrombotic events, acute kidney injury, and higher mortality. (Evidence from multiple 2021 Anaesthesia studies.) 11

D‑dimer concentrations increase markedly in DIC, and precise quantification is essential for accurate diagnosis. [14][15]

D‑dimer levels rise with advancing age; in individuals older than 80 years, the specificity of a positive D‑dimer for suspected pulmonary embolism falls to about 10 %. 10
During pregnancy, physiologic changes in coagulation commonly produce elevated D‑dimer values. 10

Atrial fibrillation is linked to modestly higher D‑dimer levels, likely due to atrial stasis and low‑grade thrombin generation. 10
Patients with ischemic stroke may show elevated D‑dimer, reflecting concurrent vascular injury and inflammation. 10

A variety of inflammatory conditions can raise D‑dimer concentrations through activation of coagulation pathways. 10

In hospitalized or acutely ill cohorts, the high prevalence of false‑positive D‑dimer results markedly limits its utility for confirming VTE without additional imaging. 10

Significant analytical variability exists among D‑dimer assays; optimal cutoff values must be calibrated to the specific methodology used. 15
D‑dimer may be reported as fibrinogen‑equivalent units (FEU) or D‑dimer units (DDU); FEU values are approximately twice those of DDU. 15